Genesis IBRC India

Genesis IBRC India Current Liabilities

Delisted·Sep 16, 2026

The Current Liabilities of Genesis IBRC India (514336.BO) as of Nov 3, 2026 is 3.03 M INR. In the previous year, Current Liabilities was 1.81 M INR — a change of 67.39% (higher).

Current Liabilities

3.03 MINR

YoY

67.39%

Last updated:

Current Liabilities of Genesis IBRC India is 2025 3.03 M INR. Current Liabilities of Genesis IBRC India was 2024 1.81 M INR. It decreases by 67.39% higher compared to the previous year.

The Genesis IBRC India Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2014
15.17 M INR
Jan 1, 2015
10.45 M INR
Jan 1, 2016
6.72 M INR
Jan 1, 2017
33,116.00 INR
Jan 1, 2018
18.64 M INR
Jan 1, 2023
1.43 M INR
Jan 1, 2024
1.81 M INR
Jan 1, 2025
3.03 M INR
The Genesis IBRC India Current Liabilities history
YEARCurrent LiabilitiesYoY
3.03 MINR+67.39%
1.81 MINR+26.68%
1.43 MINR-92.34%
18.64 MINR+56,173.02%
33,116.00INR-99.51%
6.72 MINR-35.69%
10.45 MINR-31.16%
15.17 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Genesis IBRC India Stock analysis

What does Genesis IBRC India do? Genesis IBRC India Ltd. generates revenue through the manufacturing and sale of pro-biotic products for aquaculture and fisheries, including GENPRO-WAT, PRO-VIBSOL, AMMONO-GEN, GENLACT, GROWFAST-GEN, and GEN-POND CLEAN. The company provides formulation research and development services for agriculture, aquaculture, poultry, and veterinary bio formulations, offering need-based product design, land labs, and consultation services. Its primary customers are businesses in aquaculture, fisheries, agriculture, and veterinary sectors seeking specialized pro-biotic solutions and R&D support. The company's product portfolio targets water and soil pro-biotics, vibrio controllers, ammonia and nitrites reducers, gut and intestinal pro-biotics, single cell protein, and fast decomposers. These solutions are designed to address specific challenges in aquatic and agricultural environments, such as water quality management and animal health. The firm's R&D services cater to clients requiring tailored bio-formulation development and technical expertise for their operational needs. Genesis IBRC India is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genesis IBRC India stock

Current Liabilities of Genesis IBRC India is 3.03 M INR in 2025.

Current Liabilities of Genesis IBRC India changed from 1.81 M INR to 3.03 M INR, representing a 67.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Genesis IBRC India since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Genesis IBRC India historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Genesis IBRC India

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Genesis IBRC India